Pressmeddelanden från Novonesis

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Trading by management and close relations of management 26 feb 17:04

Trading by management and close relations of management 26 feb 11:23

Trading by management and close relations of management 25 feb 08:11

Novonesis delivered strong organic sales growth of 7% in 2025 25 feb 08:09

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees 25 feb 07:57

Novonesis' Annual Report 2025 21 nov 2025 10:47

Trading by management and close relations of management 07 nov 2025 16:39

Trading by management and close relations of management 07 nov 2025 10:35

Major shareholder announcement 06 nov 2025 11:12

Novonesis delivered 8% organic sales growth in the first nine months of 2025 06 nov 2025 07:57

8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.04 nov 2025 15:11

Trading by management and close relations of management 23 okt 2025 13:03

Noma and Novonesis partner to scale deliciousness 06 okt 2025 16:00

Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters 10 sep 2025 14:09

Major shareholder announcement 08 sep 2025 08:43

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health 02 sep 2025 12:57

Trading by management and close relations of management 28 aug 2025 12:20

Amendment: Trading by management and close relations of management 28 aug 2025 11:52

Trading by management and close relations of management 22 aug 2025 16:43

Trading by management and close relations of management 22 aug 2025 12:33

Trading by management and close relations of management 21 aug 2025 08:03

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%21 aug 2025 07:58

Interim report H1 2025 20 aug 2025 19:35

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement 20 aug 2025 17:45

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement 21 jul 2025 11:56

Major shareholder announcement 07 jul 2025 08:33

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe 30 jun 2025 18:59

Transactions under Novonesis’ share buyback program 23 jun 2025 15:31

Transactions under Novonesis’ share buyback program 23 jun 2025 15:14

Major shareholder announcement 19 jun 2025 08:58

Major shareholder announcement 16 jun 2025 13:37

Transactions under Novonesis’ share buyback program 12 jun 2025 12:21

Major shareholder announcement 10 jun 2025 17:01

Transactions under Novonesis’ share buyback program 10 jun 2025 09:34

Trading by management and close relations of management 02 jun 2025 13:05

Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance 02 jun 2025 11:29

Transactions under Novonesis’ share buyback program 26 maj 2025 13:40

Transactions under Novonesis’ share buyback program 19 maj 2025 14:00

Combining EVP roles of Human Health Biosolutions and Strategy & Integration 19 maj 2025 13:51

Transactions under Novonesis’ share buyback program 12 maj 2025 13:43

Transactions under Novonesis’ share buyback program 12 maj 2025 13:36

Trading by management and close relations of management 08 maj 2025 08:00

Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook 08 maj 2025 07:58

Interim report Q1 2025 05 maj 2025 15:18

Transactions under Novonesis’ share buyback program 28 apr 2025 09:17

Transactions under Novonesis’ share buyback program 22 apr 2025 17:00

Andrew Taylor joins Novonesis’ Executive Leadership Team 22 apr 2025 14:25

Transactions under Novonesis’ share buyback program 14 apr 2025 10:26

Transactions under Novonesis’ share buyback program 07 apr 2025 12:29

Transactions under Novonesis’ share buyback program 03 apr 2025 17:43

Resolutions from the Annual General Meeting 2025 31 mar 2025 11:14

Transactions under Novonesis’ share buyback program 26 mar 2025 17:05

Trading by management and close relations of management 24 mar 2025 17:00

Transactions under Novonesis’ share buyback program 17 mar 2025 11:36

Transactions under Novonesis’ share buyback program 11 mar 2025 12:00

Invitation to the Annual General Meeting 10 mar 2025 15:08

Transactions under Novonesis’ share buyback program 06 mar 2025 14:22

Trading by management and close relations of management 05 mar 2025 13:52

Election of employee representatives to the Board of Directors 05 mar 2025 09:33

Trading by management and close relations of management 05 mar 2025 08:42

Initiation of share buyback program 03 mar 2025 12:16

Trading by management and close relations of management 27 feb 2025 09:39

Trading by management and close relations of management 26 feb 2025 08:04

12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025 26 feb 2025 07:58

12M 2024 Company announcement 21 feb 2025 12:24

Change to the Executive Leadership Team 11 feb 2025 07:13

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance 11 feb 2025 06:57

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance 03 jan 2025 11:23

Trading by management and close relations of management 17 dec 2024 10:00

Change to Novonesis’ Board of Directors 29 nov 2024 15:22

Major shareholder announcement 27 nov 2024 11:09

Major shareholder announcement 25 nov 2024 13:43

Major shareholder announcement 20 nov 2024 15:44

Trading by management and close relations of management 18 nov 2024 13:54

Novonesis will host an educational conference call on Energy on December 18 13 nov 2024 12:57

Major shareholder announcement 07 nov 2024 08:02

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%07 nov 2024 07:59

Trading statement 9M 2024 04 nov 2024 13:21

Trading by management and close relations of management 04 nov 2024 10:08

Trading by management and close relations of management 23 okt 2024 14:36

Major shareholder announcement 21 okt 2024 15:01

New employee-elected board member 16 okt 2024 09:58

Trading by management and close relations of management 15 okt 2024 14:25

Major shareholder announcement 09 okt 2024 10:37

Major shareholder announcement 03 okt 2024 09:29

Major shareholder announcement 16 sep 2024 16:14

Trading by management and close relations of management 12 sep 2024 11:31

Trading by management and close relations of management 11 sep 2024 13:08

Trading by management and close relations of management 10 sep 2024 12:33

Major shareholder announcement 06 sep 2024 08:51

Major shareholder announcement 05 sep 2024 13:07

Major shareholder announcement 02 sep 2024 18:36

Trading by management and close relations of management 02 sep 2024 18:27

Trading by management and close relations of management 30 aug 2024 12:17

Trading by management and close relations of management 29 aug 2024 15:17

Major shareholder announcement 27 aug 2024 16:34

Novonesis delivers strong half-year results and increases full-year outlook 27 aug 2024 16:30

Interim Report H1 2024 27 aug 2024 16:29

Novonesis increases outlook for full year 2024 16 aug 2024 16:40

Major shareholder announcement